These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2063365)

  • 41. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
    Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
    Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flow cytometric DNA-ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract.
    Smit VT; Fleuren GJ; van Houwelingen JC; Zegveld ST; Kuipers-Dijkshoorn NJ; Cornelisse CJ
    Cancer; 1990 Oct; 66(8):1843-9. PubMed ID: 2208040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic and prognostic value of DNA cytometry in gynecologic cytology.
    Böcking A; Chatelain R
    Anal Quant Cytol Histol; 1989 Jun; 11(3):177-86. PubMed ID: 2663008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
    Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
    Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ploidy disturbances in endometrial and ovarian carcinomas. A review.
    Iversen OE; Laerum OD
    Anal Quant Cytol Histol; 1985 Dec; 7(4):327-36. PubMed ID: 3911973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Are centrosomal abnormalities correlated to DNA ploidy in breast cancer?].
    Sakr R; Fleury J; Prengel C; Roynard P; Daraï E; Uzan S; Rouzier R; Bernaudin JF
    Ann Biol Clin (Paris); 2011; 69(2):181-9. PubMed ID: 21464011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA ploidy and steroid receptors as predictors of disease course in patients with endometrial carcinoma.
    Iversen OE; Utaaker E; Skaarland E
    Acta Obstet Gynecol Scand; 1988; 67(6):531-7. PubMed ID: 3239384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical significance of the determination of cellular DNA content in gynecologic neoplasms].
    Li ZX
    Zhonghua Fu Chan Ke Za Zhi; 1991 May; 26(3):177-9. PubMed ID: 1874062
    [No Abstract]   [Full Text] [Related]  

  • 51. [Molecular genetic of gynecological cancer].
    Yanaihara N; Okamoto A; Yanagida S; Ochiai K; Tanaka T
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():489-93. PubMed ID: 20976924
    [No Abstract]   [Full Text] [Related]  

  • 52. Oncogenes in gynecologic malignancy.
    Baker V
    Curr Opin Obstet Gynecol; 1992 Feb; 4(1):75-80. PubMed ID: 1543833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined analysis of ploidy and cell kinetics on fine-needle aspirates from breast tumors.
    Martelli G; Daidone MG; Mastore M; Gabrielli GM; Galante E; Pilotti S; Silvestrini R
    Cancer; 1993 Apr; 71(8):2522-7. PubMed ID: 8453575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ploidy level and short-time prognosis of early cervix cancer.
    Jakobsen A
    Radiother Oncol; 1984 Jan; 1(3):271-5. PubMed ID: 6505263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BRCA1 mutation site may be linked with nuclear DNA ploidy in BRCA1-mutated ovarian carcinomas.
    Aghmesheh M; Saxena A; Niknam F
    Asia Pac J Clin Oncol; 2015 Jun; 11(2):135-41. PubMed ID: 25428229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular markers of breast and ovarian cancer.
    Steel CM
    Dis Markers; 1991; 9(3-4):213-23. PubMed ID: 1813211
    [No Abstract]   [Full Text] [Related]  

  • 57. Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus.
    Atkin NB
    J Natl Cancer Inst; 1976 May; 56(5):909-10. PubMed ID: 994202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Properties of cancer cell DNA affects the prognosis].
    Kildal W; Pradhan M; Cyll K; Jacobsen JE; Kristensen GB; Danielsen HE
    Tidsskr Nor Laegeforen; 2017 Oct; 137(19):. PubMed ID: 29043733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The clinical value of DNA ploidy in ovarian cancer].
    Obrebowska A; Spaczyński M
    Ginekol Pol; 1997 Oct; 68(10):478-82. PubMed ID: 9780508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of pS2 messenger RNA in gynecological cancers.
    Wysocki SJ; Hahnel E; Masters A; Smith V; McCartney AJ; Hahnel R
    Cancer Res; 1990 Mar; 50(6):1800-2. PubMed ID: 2306733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.